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Abstract 
 
How does immune system evolve functional proteins – potent antibodies - in such a short 
time? We address this question using a microscopic, protein-level, sequence-based model 
of humoral immune response with explicitly defined interactions between 
Immunoglobulins, host and pathogen proteins. Potent Immunoglobulins are discovered in 
this model via clonal selection and affinity maturation. Possible outcomes of an infection 
(extinction of cells, survival with complete elimination of viruses, or persistent infection) 
crucially depend on mutation rates of viral and Immunoglobulin proteins. The model 
predicts that there is an optimal Somatic Hypermutation (SHM) rate close to 
experimentally observed 10-3 per nucleotide per replication. Further, we developed an 
analytical theory which explains the physical reason for an optimal SHM program as a 
compromise between deleterious effects of random mutations on nascent maturing 
Immunoglobulins (adversity) and the need to generate diverse pool of mutated antibodies 
from which highly potent ones can be drawn (diversity). The theory explains such effects 
as dependence of B cell fate on affinity for an incoming antigen, ceiling in affinity of 
mature antibodies, Germinal Center sizes and maturation times.  The theory reveals the 
molecular factors which determine the efficiency of affinity maturation, providing insight 
into variability of immune response to cytopathic (direct response by germline 
antibodies) and poorly cytopathic viruses (crucial role of SHM in response). These results 
demonstrate the feasibility and promise of microscopic sequence-based models of 
immune system, where population dynamics of evolving Immunoglobulins is explicitly 
tied to their molecular properties. 
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Introduction 
 
              Adaptive immunity is one of the marvels of Biology and one of its greatest 
mysteries. Organisms have to respond to novel antigens which they have not seen before 
and this response should be specific in order to avoid attacking its own proteins 
(autoimmunity).  This task represents  a clear example of adaptation, which occurs in a 
shortest possible time frame of days to weeks, while normal evolutionary  processes of 
adaptation take anywhere from years to millions of years (Elena and Lenski 2003). The 
adaptive humoral immunity is based on the ability of Immunoglobulins to bind antigen 
ligands and to quickly evolve protein-protein (in case of protein-based antigen) or more 
generally protein-ligand interactions. Immunoglobulin-based adaptive immunity 
represents a rapid and effective search in protein sequence space under a number of 
constraints. Understanding basic principles of immune response, besides its obvious 
importance for medicine, is also important for fundamental understanding of Darwinian 
evolution and adaptation.  
      The modern view on  sequence evolution in immune response stems from Burnet 
hypothesis that selection of B-cells expressing potent Immunoglobulins occurs in two 
stages (Burnet 1959). At the first stage  (clonal selection) a small fraction of naïve 
antibodies that are able to bind the antigen with moderate affinity are found in a diverse 
germline pool. Subsequently, these cells are activated to proliferate and they accumulate 
mutations which increase its affinity to antigen (affinity maturation). Affinity maturation 
has been indeed discovered (Eisen and Siskind 1964) and subsequent experimental 
studies provided important insights into molecular mechanisms of adaptive immunity 
consistent with Burnet’s model (Jacob et al. 1991; Jacob and Kelsoe 1992; Liu et al. 
1992; Shih et al. 2002). Experiments found that some specificity for an antigen indeed 
exists in germline pool of Immunoglobulins before it is encountered (Eisen and Siskind 
1964; Jacob and Kelsoe 1992; Rajewsky 1996; Paus et al. 2006).  Recent real time 
imaging experiments clarified many mechanistic aspects of affinity maturation taking 
place in Germinal Centers (GC) (Allen et al. 2007).  
            These important developments notwithstanding, it is difficult to grasp 
fundamental physical principles of adaptive immunity from the molecular detail picture 
emerging in experiments. It may be not apparent which evolutionary ‘’solutions’’ for 
mechanism of immunity are robust and which ones represent the result of particular 
random evolutionary ‘’choices’’.  It is as if one were to try to grasp the principles of 
thermodynamics by dissecting modern internal combustion engines. 
Here we take a complementary bottom-up approach by studying adaptive humoral 
immunity within a model which is realistic enough to contain sequence-based description 
of stability of proteins and their interactions yet is sufficiently coarse-grained to allow 
study of immune response in an ab initio simulations and analytically. Our main goal is to 
uncover the minimal requirements and physical principles on which a successful adaptive 
immune response can be built  and to investigate whether existing immune systems are 
based on these physical principles. 
Recently we developed a model which combines microscopic, sequence-based, 
description of dynamics of genes and stability of encoded proteins with cell population 
dynamics governed by exact relationship between genotype and phenotype (Zeldovich et 
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al. 2007b). This model was applied in (Zeldovich et al. 2007b) to study early evolution of 
Protein Universe. Here we extend this approach to study adaptive humoral immunity. We 
explicitly determine stability and interactions between viral and host defense 
(Immunoglobulin-like, Ig) proteins from their sequences. On a cellular level our model 
accounts for replication of host cells, viruses and B cells (see below) and mutations of 
their sequences.  We build the model bottom up based on simplest ‘’common-sense’’ 
mechanistic assumptions and sequence-based molecular description of relevant proteins 
and their interactions. (see Figure 1) Specifically we make the following four mechanistic 
microscopic assumptions. First, we assume that viruses invade host cells and cause their 
death by lysis when the number of viral particles replicating in a cell exceeds the lysis 
threshold.   Second, we assume that stronger binding between Ig proteins and viral 
antigens inhibits replication of viruses (i.e. decreases effective viral replication rate). 
Third,, to account for B-cell activation mechanism, we assume that the rate of B-cell 
division increases upon stronger binding between viral antigens and Ig proteins. Finally 
we assume that B-cell activation is impaired if Ig proteins bind cell’s own proteins, 
roughly modeling the effect of protection against autoimmunity, via clonal exclusion of 
helper T-cells. For simplicity, we model the complex processes of B-cell activation and 
antibody production, differentiation and excretion, via the dependence of dynamics of 
production of Ig proteins on their physical interactions with the antigen (virus) and host 
cell proteins. Therefore, in the model, B-cells, antibodies, and Ig are merged into a single 
entity (an Ig protein) whose population dynamics is separate from that of host cells and 
viruses. Although all three terms are used in the text as appropriate, we stress that in the 
model, they all refer to the same object, Ig protein. The  technical details of the model are 
given in the Methods section and in the Supporting Information.  
 
 
Figure 1.  Schematic representation of the model. Viruses (red stars) may penetrate cells 
and reproduce there, eventually causing lysis. Antibodies (Y-shaped symbols) bind to 
viruses and slow down their replication. The replication rate of the antibodies increases 
with the strength of their interaction with viruses (B-cell activation) and decreases with 
the strength of their interaction with host cell proteins (autoimmunity). 
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We show that an effective adaptive immune response very similar to real one 
develops in this microscopic model. Most importantly, we demonstrate that our model of 
adaptive dynamic immune response captures many complexities of real immune systems 
and helps to explain a variety of recent observations concerning immune response to 
pathogens in several experimental models. 
Dynamics of the system establishes a qualitative outcome of an infection in this 
model: healing (survival of host cells with complete elimination of viruses), extinction of 
host cells, or development of a persistent infection, where the cells and viruses coexist 
and the fraction of infected cells remains constant with time. Qualitatively, one can 
expect that for a very slowly mutating virus, strongly virus-binding Ig proteins will 
evolve, suppress virus growth, and eliminate the virus population. On the other hand, the 
speed at which such immunity evolves is fundamentally limited by the mutation rate of 
the Ig protein, and by the speed at which the advantageous sequences spread through the 
population. Therefore, if the mutation rate of viruses is high enough, their sequence 
change can outpace the evolution of cellular response, resulting in a robust lethal or 
persistent infection.  
Below, we present the results of simulations and analysis for this ab initio, 
microscopic model of immune response, and show that physics-based, sequence-level 
model can provide crucial insights, on all scales, into the development and dynamical 
regimes of immune response.   Further we present a detailed analytical theory that 
provides quantitative description of evolution and selection of potent Immunoglobulin 
sequences emerging in response to an Antigen presentation. 
 
Results and discussion 
 Extensive simulations of the model over a broad range of parameters (B-cell and 
virus replication rates, and mutation rates of Ig and viruses) showed that the outcome of 
an individual simulation run falls into one of the three categories: healing, H, with 
complete extinction of the virus; extinction of the host, E, (and the ensuing extinction of 
the virus); and persistent infection, P, where viruses and cells coexist with neither species 
winning the competition. The probability of each of the three outcomes depends on the 
parameters of    the model, most notably on mutation rates of Ig and viral genes.  
 Figures 2A and 2B represent a phase diagram of the model, where the color 
corresponds to the probability of healing (Figure 2A) and persistent infection (Figure 2B) 
at the given mutation rates of virus mv and of Ig protein mIg. For low-to-moderate virus 
mutation rates, the most notable result is the existence of the optimal Ig mutation rate, 
which maximizes the probability of healing for the given mv (Figure 2A and Figure 7). 
Qualitatively, for a very low Ig mutation rate, strongly binding Ig sequences can not 
evolve before viruses spread in the population and cause lysis, eliminating the host cells. 
On the other hand, if the Ig mutation rate is too high, favorable Ig sequences mutate away 
from strong binding before their carrier antibodies proliferate and eliminate the virus. An 
analytical estimate of the optimal mutation rate of the Ig sequences is presented below. At 
higher viral mutation rates, the typical outcome of a simulation run is either extinction or 
persistent infection (Figure 2B), as the antibodies can not keep up with the fast-mutating 
viral population, which thus effectively evades immunity.  
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Figure 2. Emergence of immunity. (A) Phase diagram showing the probability of healing 
of host cells in 200 runs as function of the mutation rates of Ig and viral proteins, in 
mutations per protein per time step. (B) Phase diagram showing the probability of 
persistent infection. The labels on the contour lines are the probabilities of healing in (A) 
or persistent infection in (B).  
 
Figures 3A and 3B present the population dynamics of cells and viruses, 
respectively, for representative simulation runs corresponding to healing (black curves), 
persistent infection (blue curves), and extinction (red curves) cases. One can see that in 
all cases, infection is followed by an incubation period during which the host cell 
population remains constant, and the virus population increases until lysis threshold is 
achieved in the majority of cells. Ensuing lysis causes an abrupt drop in the cell 
population (Figure 3A). The duration of the incubation period depends on the virus 
replication rate. At the same time, B-cells producing antibodies which strongly bind to 
viruses, acquire selective advantage, as their replication rate is higher, while virus 
replication is hindered by strongly bound Ig.  
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Figure 3. Population dynamics of the model (A) Population of cells as a function of time 
in representative simulation runs resulting in healing (H) at mv=0.0003 and mIg=0.08, 
extinction of host cells (E) at mv=0.0005 and mIg=0.04 or persistent infection (P) at 
mv=0.0008 and mIg=0.001. Infection occurs at t=2001. (B) Population of viruses in the 
same simulation runs. Red lines in A-B correspond to extinction outcome, blue lines to 
persistent infection and black lines to healing. 
 
 
As a result the average interaction strength between Ig and virus proteins Pint (see 
Methods) increases with time (Fig.4). In a particular run (infection event), the outcome 
(in a certain range of viral, cell and B-cell replication rates and viral and Ig mutation 
rates) largely depends on random events during the competition of Ig and viral sequences, 
affecting binding between Ig and viruses, their population dynamics and ultimately the 
fate of the host cells.  
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Figure 4 Averaged (over all Ig proteins and viruses) strength of interaction Pint between 
viral and Ig proteins shows that strongly binding Ig’s gain selective advantage, rapidly 
increasing Pint as the cells try to overcome infection.  
 
 
 
 To understand the behavior of the model, let us note that healing occurs mainly 
via dilution of viruses within the host cells, when the cell replication rate bcell exceeds that 
of viruses bv. Using Eq.(21) of Methods which defines dependence of  viral replication 
rate on antigen-Ig interaction strength we get: 
 
                                b
cell > bv = b0v Pnat (v)[1− Pint (Ig,v)]  
 
or                                                                                                                   (1) 
 
 
 
Pint (Ig,v) > 1− bcell b0v Pnat (v)( )~ 0.8  
 
for the replication rates used in the model (see Methods). Thus, healing outcome may 
occur only if sufficiently strong binding between Ig proteins and viruses, Pint>0.8 
evolves. Further growth of affinity beyond Pint = 0.8  does not confer selective advantage 
and is therefore limited. Conversely, lysis occurs when the population of viruses within 
an infected cell pv reaches the lysis threshold L before cell division, i.e. over times on the 
order of 1/bcell. A similar calculation shows that such outcome is possible 
for
 
Pint (Ig,v) < 1− (L −1)bcell b0v Pnat (v)( )~ 0.4 . Indeed, as seen in Figure 4, in the 
extinction case the interaction strength Pint never exceeded 0.35 (no strong-binding Ig had 
evolved), and was significantly higher in cases of persistent infection and healing, with 
healing observed when Ig-antigen interactions are strongest. Lower and upper thresholds 
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on affinity in B-cell activation were also observed in experiment (Batista and Neuberger 
1998). 
Germline immune response to evolving viruses – the advantage of being a moderate 
parasite. 
 An important ecological implication of the above considerations is a non-
monotonic dependence of effective virus fitness on strength of its interaction with 
germline Ig. Indeed, viruses which are prone to strong binding to Ig (high Pint) replicate 
slowly and are removed from population via dilution as their carrier cells divide faster 
than the viruses within the cells replicate. On the other hand, very weakly binding viruses 
are so efficient at evading immune defense that they quickly destroy their carrier cells 
through lysis, leading to the extinction of the populations of both host cells and viruses. 
This can be seen most strikingly in simulations with a fixed antibody repertoire, 
representing germline Igs i.e. mIg=0. We find that viruses evolve a certain intermediate 
interaction strength, steering away both from the removal by immune response and from 
prematurely killing every host cell. Figure 5 shows histograms of interaction strength Pint 
for mIg=0 for two values of virus mutation rate, mv=10-4 (Figure 5A) and mv=10-1 (Figure 
5B). For the lower value of virus mutation rate, the viruses are so efficient at evading and 
destroying the host (under non-evolving immunity conditions)  that their population dies 
out (together with the host) while retaining extreme virulence (low Pint). On the other 
hand, the population of rapidly mutating viruses (mv=10-1) is diverse enough to evolve 
towards maximum fitness, which results in a persistent infection, with gradual upward 
evolution of the Pint distribution towards a stationary, moderately virulent state. 
Interestingly, the interplay between molecular and ecological effects in this model results 
in a host-pathogen coexistence where pathogens require some level of host defense 
(immune response) for their survival. A very similar behavior, where the primary defense 
is provided by naïve serum germline antibodies, was observed with highly cytopathic 
viruses such as VSV (Roost et al. 1995; Hangartner et al. 2006).   
 
 
Figure 5. Coevolution of viruses and host cells with germline Igs only, i.e.,  mIg=0. (A) A 
slowly mutating virus remains extremely virulent, Pint <0.4, and kills the host and the 
virus population. (B) At a higher virus mutation rate, development of moderately strong 
interactions between viruses and Ig leads to a persistent infection, as the Ig can not 
eliminate the virus, and the virus, in turn, is too weak to kill the host. 
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Clonal Selection and Affinity maturation 
 Now we consider higher Ig mutation rates reflective of the phenomenon of 
somatic hypermutaion (SHM) in GC (Jacob et al. 1991; Kleinstein et al. 2003).  Our main 
finding here is that at higher Ig mutation rates, selection of specific, strongly binding Ig 
proteins proceeds in our model via clonal selection with subsequent affinity maturation. 
In Figure 6A we present the histogram of the Ig-to-virus binding strength Pint 
distributions at four time slices. Immediately after infection, t=2005 (black curve), most 
of the Ig sequences exhibit a marginal binding to the viral antigen with Pint~0.10, typical 
of two random proteins in this model. However, a small fraction of B-cells expresses Ig 
molecules with  relatively strong binding, Pint>0.35 (tail of the distribution, shaded area). 
Subsequently, such cells enjoy a selective advantage – they are activated to divide faster 
(see Eq. (3) in Model and Methods), and their proportion in the population increases 
(t=2030, red curve). This is similar to the natural clonal selection process (Jacob et al. 
1991; Mehr et al. 2004) Furthermore, after  (moderately) binding sequences have been 
discovered, they undergo mutations with subsequent selection, corresponding to affinity 
maturation increasing the binding strength Pint to its final value of ~0.7 (t>2050, green 
and blue curves). To confirm that strongly binding Ig’s are normally direct descendants 
of the original moderately binding sequences selected at the first – clonal selection – 
stage of the immune response, we marked initial antibodies with Pint>0.35 as ‘’red’’, and 
postulated that their progeny retains the ‘’red’’ color. In Figure 6B, we plotted the 
fraction of the ‘’red’’ antibodies in the population. One can see that the fraction of the 
‘’red’’ antibodies increases with time, and approaches unity as the system recovers from 
the infection (cf. Figure 3). Therefore, virus removal is mostly accomplished by direct 
descendants of the germline B-cells expressing Ig sequences which accidentally had a 
certain binding affinity to the incoming antigen and have been subsequently amplified 
and optimized via a two-stage process of clonal selection and affinity maturation. Our 
simulations suggest that the primary role of clonal selection is to amplify B-cells with 
moderately binding sequences from a diverse germline pool.  As a next step, cells 
carrying clonally selected Ig genes undergo improvement by specific mutations 
dramatically increasing the binding strength. Evidently, such mutations can be efficiently 
discovered only during mutagenesis in a pool of moderate binders, rather than by pure 
chance among pseudorandom sequences.  
 Next, we study the distribution of sequences of evolving Ig proteins. In Figure 6C, 
we present the measure of sequence diversity - sequence entropy -  of evolved Ig proteins 
(black curve) and Ig-to-virus binding strength Pint (red curve) as a function of time for a 
healing case. The plot shows that discovery of strongly binding Ig proteins, manifested in 
a sharp increase in Pint , is accompanied by an initial  drop in  sequence entropy of Ig 
proteins – reflecting strong selection of mature Ig molecules resulting in an almost 
monoclonal character of emerging mature antibody pool. As the infection is being 
eliminated, both population and sequence diversity of Ig proteins increase. Notably, an 
increase in sequence entropy does not lead to a decreased interaction strength Pint 
suggestive of availability of large number of mutations which do not affect binding 
affinity.  This is reflective of significant plasticity in sequence space. Our finding that  
population of mature strongly binding Ig is highly diverse, yet it is monoclonal in its 
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ancestry is in accord with classical experimental observations that individual GCs 
produce mature monoclonal B cells (Jacob et al. 1991).  
 
 
Figure 6. Clonal selection and affinity maturation. (A) Histogram of the binding strength 
Pint  in the ensemble of Ig molecules at various times. From t=2001 to t=2030, clonal 
selection increases the fraction of Ig’s strongly binding the virus: the tail of the 
distribution becomes more prominent, while the maximum is unmoved. As time goes on, 
mutations in previously selected Ig genes further increase Pint and shift the distribution to 
the right until monoclonal population of strongly binding Ig molecules emerges. (B) We 
marked the antibodies with Pint>0.35 at t=2001 (shaded area in (A)) as ‘’red’’ and 
followed the fraction of their progeny in subsequent populations. As the infection is being 
eliminated, most of the Ig’s are descendants of the few strongly binding sequences 
amplified via clonal selection. (C) Sequence entropy of the evolving Ig proteins (black 
line) and their binding strength Pint as a function of time (red). Development of immunity 
is initially accompanied by a rapid increase of Pint and a decrease of the sequence 
entropy of Ig proteins, confirming the appearance of a monoclonal Ig population at the 
initial stage of infection. However subsequently, the pool of Immunoglobulins gets more 
diverse resembling of a polyclonal population. 
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Theory of affinity maturation and optimal rate of SHM. 
  Our simulations suggest the existence of optimal rate of SHM at which immune 
response is most efficient (see Figure 2A and (Celada and Seiden 1996; Pierre et al. 
1997)). Qualitatively, this is due to the fact that too low mutation rate of Ig  proteins will 
prevent affinity maturation while too high mutation rate could result in prevalence of 
predominantly deleterious mutations which destroy even moderate binding of Ig to 
antigens found at the clonal selection stage.  
       A more quantitative analysis is based on the MacLennan model of affinity maturation 
in GCs (MacLennan 1994; Allen et al. 2007). Early proliferation of B cells in GC occurs 
prior to formation of Dark Zone (DZ) and Light Zone (LZ).  SHM accompanied by 
exponential growth of B cells takes place in DZ. B cells in DZ (centroblasts) 
downregulate expression of Igs (Allen et al. 2007) and therefore are not subject to 
selection at this stage. Expansion of centroblasts in DZ creates a diverse repertoire of 
mutated sequences of VH,L regions of Igs. Selection takes place most likely in the LZ 
where high concentration of Ag is present after which B-Cells expressing Ig’s with 
sufficiently improved affinity are positively selected and the ones showing low affinity 
Igs are removed via apoptotic pathway (Berek et al. 1991; Jacob et al. 1991; Batista and 
Neuberger 1998; Allen et al. 2007). While the molecular details of this positive selection 
have not been fully established we based our theoretical analysis on the following 
dynamic postulates: 
1) B cells having some initial affinity to the antigen (free energy of binding) G0 clonally 
expand to become centroblasts in the DZ (Berek et al. 1991).  
2) In the DZ centroblasts enter cell cycle where they proliferate and undergo stochastic 
mutation program over t generations with mutation rate m (per VH,L genes per 
generation). Each cell acquires a random number of mutations N, varying from cell to cell 
due to intrinsically stochastic nature of SHM.  As Ig genes accumulate mutations in the 
process of SHM, the total change in binding free energy for Ag is additive with respect to  
mutations in CDR of this gene.   
       In order to understand conceptually why this picture implies the existence of an 
optimal SHM program consider first an (oversimplified) case when CDRs of all VH,L 
genes acquire an identical number of mutations mt   1. The total change in binding free 
energy between Ag and Ig is additive with respect to all mutations. Additivity of free 
energy effects of mutations implies that probability density for the total free energy 
change ΔG  over complete SHM program follows a Gaussian distribution according to 
the Central Limit Theorem: 
 
 P ΔG( )= 1
2πmtσ 2 e
− ΔG−mth( )2
2mtσ 2        (2) 
 
where 
 
 h = p ΔG( )
−∞
∞
∫ ΔGdΔG;   σ 2 = p ΔG( )
−∞
∞
∫ ΔG2dΔG − h2  
are average and dispersion of change of binding free energy upon a single mutation; 
h > 0  implies that mutations in the binding interface on average weaken binding, which 
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is indeed the case in experiment (Chen et al. 1999). Now we assume that upon exit from 
DZ into LZ only those  B-cells are clonally expanded whose Ig binding free energy to Ag 
reaches or falls below the threshold value Gc . In this case the probability of successful 
affinity maturation (i.e. fraction of B cells which differentiate into Ig producing plasma 
cells or memory cells) is apparently: 
 
 PAM = P ΔG( )
−∞
Gc −G0∫ dΔG ≈ erfc −(Gc − G0 )( )≈ − 1π mtσGc − G0 − mth e
− Gc −G0 −mth( )2
2mtσ 2 (3) 
 
where we used an asymptotic expression for the complementary error function assuming 
that Gc − G0 − mth( )/ mtσ   1. When h>0 this expression reaches a maximum at  
 
                          (mt)opt = − Gc − G0h                                         (4) 
 
The reason that random mutations in CDR tend to be destabilizing in average is because 
B cells enter the DZ of GC after initial clonal selection with some initial potency to bind 
Ig with binding free energyG0 < 0 . In that case random mutations on the binding surface 
of Igs produced by these initial centroblasts would have a tendency to weaken this initial 
binding affinity. In other words an estimate of  h  for a binding surface  
 
         
                                                                 h ≥ −αG0                                (5) 
 
where  α   1describes how mutation in a single amino acid changes binding free energy 
in a potent interface. The probability of successful affinity maturation at the optimal 
SHM program when mt = mt( )opt  is then  
 
 
 PAM
opt = e−
2 Gc −G0( )h
σ 2       (6) 
 
 
This quantity increases when G0 → Gc , which is natural because the range of necessary 
affinity increase shrinks in this case.   
     This simple example illustrates the physical reason for an optimal mutation rate and/or 
duration of SHM (SHM program). Indeed, as random mutations accumulate they in 
average weaken binding. However by virtue of additivity of energetic effects of 
individual mutations, they create a more diverse pool of B-cells (i.e. dispersion of binding 
free energies between B-cells after N mutations grows as σ N ) and this diversity 
increases the chance that there appear B-cells which produce sufficiently strong binding 
Igs which then can further expand and differentiate into plasma or memory cells.. Clearly 
a compromise between average mutational destabilization of already binding surfaces and 
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diversity can be achieved only at some optimal total number of mutations in the SHM 
program (see Fig.7A for a graphic illustration). 
      The above illustrative considerations pertain to an oversimplified case when all 
centroblasts experience the same number of mutations during their SHM program. In 
reality the number of mutations acquired in a centroblast during SHM program is itself 
random, the total number of mutations is additive over generations and therefore the 
probability that a centroblast acquires N mutations can be well approximated by a 
Gaussian: 
 
          ΙN ≈ 12πmt e
− N −mt( )2
2mt        (7) 
 
 
  
(the relation between average and standard deviation  in Eq.(7)  follows from the fact that 
the number of mutations at each round of replications follows a Poisson distribution)  
The fraction of B-cells which underwent successful AM is then given by: 
 
 
 
PAM = d(ΔG) IN
N =0
∞∑
−∞
Gc −G0∫ PN ΔG( )(8) 
 
Using the asymptotic expression for the complementary error function, Eq.3, and Eq.4 for 
mt( )opt  we get: 
 
                             PAM ≈ e
− h
2
2σ 2
mt( )opt +N( )2
N
− N −mt( )2
2mt
2 mt( )opt + N( ) h22σ 2N 2πmtN =0
∞∑   (9) 
 
 
We approximate the sum in Eqs. (8,9)  by its maximum term  in N corresponding to most 
probable number of accepted mutations N = %N   in selected B-cells. Denoting the average 
fraction of accepted mutations 
 
x = %N
mt
  we get in the same asymptotic approximation the 
equation that determines the largest term (in N) in series of Eq.(9)  
 
 
           
h2
2σ 2
mt( )opt
mt
⎛
⎝⎜
⎞
⎠⎟
2
1
x2
+1− h
2
2σ 2 = x          (10) 
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This equation determines the most probable total number of mutations in matured  B cells 
which were selected to become plasma or memory cells. 
      Equation (10) can be solved numerically. It is also important to note that for the 
optimal SHM program mt = mt( )opt it has a solution x=1 which corresponds to highest 
probability  that B cells successfully mature. 
      Substituting (10) into (9) we get for the probability that a B cell matures: 
 
  PAM = e
− h
2
2σ 2
mt x+ mt( )opt
mt
⎛
⎝⎜⎜
⎞
⎠⎟⎟
2
x
− mt x−1( )2
2
2 mt( )opt + xmt( ) πh2σ 2x
      (11). 
 
Where  x  is determined from solution of Eq.(10).  
       Antibodies which matured to reach sufficient affinity (i.e. binding free  energy 
stronger than Gc ) clonally expand upon their exit from DZ (O'Connor et al. 2006). We 
deem AM to be successful if at least a single mature B-cell (out of M total generated in 
GC) exists in the centroblast population which may be sufficient for subsequent clonal 
expansion.  Using Eq.11, we finally obtain the probability that AM is successful: 
 
 PGC = 1− e−MPAM      (12) 
 
This result imposes the condition on the number of B cells in GC which have to be 
generated to  assure a successful immune response: 
 
 M ≥ 1
PAM
           (13)  
 
These theoretical results can be compared with simulations.  The healing outcome in 
simulations  occurs when strongly binding Igs with Pint > 0.8 evolve  and clonally expand 
(see Eq.1 and Fig.4), which implies that 
 
                                                     Phealing = CPGC           (14) 
 
We plot the probability of healing in simulations Phealing  as a function of Ig mutation rate 
(see Fig.7B). In order to compare theory with simulations we need to know the following 
parameters: C, M , t, h
2
2σ 2 ,mopt . We can estimate most of them directly from simulations. 
mopt is determined  as a mutation rate m at which healing probability is maximum, 
t ≈ 50 can be estimated as time when diversity of Ig binding significantly increases 
indicative of appearance of mature Ig molecules (see Fig.6) and M=8000 is population of 
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Ig cells in simulation. That leaves us with only two adjustable parameters, C and 
h2
2σ 2 .  
Comparison of theory with simulations is shown in Fig.7B.  
  
 
Figure 7. The existence of an optimal SHM rate of Ig. (A) A cartoon plot provides a 
conceptual explanation of why an optimal mutation rate exists. Three solid lines in the 
plot represent the distribution of binding energy variation after characteristic period 
(topt) of affinity maturation at low (red), optimal (blue), and high (green) mutation rate. 
The more mutations are accumulated, the more rightward shift occurs because the 
majority of random mutations are deleterious to the affinity of Ig antigen interactions. 
The probability of the affinity maturation is the area under the distribution curve to the 
left of the dashed line, marking the threshold of the binding free energy for affinity 
maturation. At low mutation rate (red line) too few mutations have occurred, therefore 
the width of the distribution is too narrow to allow affinity maturation. The probability of 
affinity maturation is still low at high mutation rate, because the peak of the distribution 
is too far away to cross the dashed line, despite of the wide variation of the distribution – 
too many deleterious mutations have occurred. At the optimal mutation rate (blue line), 
the probability is maximized by the moderate width of the distribution and shift of the 
peak.  
(B) Probability of healing as function of Ig mutation rate for the viruses whose mutation 
rate is mv=0.0001 (red) and 0.0003 (black). Dots are actual simulation data; dashed 
lines are obtained by nonlinear regression fit of the analytical expression Eq. (14) with 
PAM from Eqs.(11,12) using  Mathematica 6.0. The approximate values of mopt,  
h2
2σ 2  and 
M are obtained from simulation data as 0.1 (0.12), 0.5 (0.3), and 8000 (8000) for 
mv=0.0001 (mv=0.0003) respectively, and two fitting parameters d and topt were 
determined by fitting Eq. (12) to the probability profile from the simulation. The fitted 
parameters are d=0.60 (d=0.53) and t=31.68 (t=43.64). The optimal activation time of 
43.64 at  mv=0.0003 is very close to the optimal activation time in simulations (~50, see 
Fig. 6). 
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The optimal SHM program mt( )opt  depends on the initial affinity of the clonally selected 
antigen, i.e. G0 :  The optimal mutation rate and/or duration of SHM program decreases 
when Ags of higher affinity to germline Igs are presented as can be discerned from Eq.4. 
Do organisms adjust their SHM program in response to a presented Ag to keep it close to 
optimal or there is a preset SHM program, i.e. mt  is constant regardless of which antigen 
is presented? The experimental literature on that subject is somewhat controversial. 
Authors of Ref (Shih et al. 2002) argue that there is a fixed SHM program while the data 
of Noelle and coworkers may imply that the SHM program (i.e. the number of mutations) 
adjusts to variation in initial Ag affinity (O'Connor et al. 2006). Both papers compare the 
numbers of mutations observed in CDRs with mutations in fragments which are 
presumably not under selection for affinity (intron in (Shih et al. 2002) and framework 
(FR) region in (O'Connor et al. 2006)).  While in the former case the number of mutations 
was the same for high- and low- affinity antigens it was dramatically different in the latter 
case providing some support to the view that the mutation rate and/or duration of the 
SHM program may adjust to specific antigens. Below we briefly discuss both scenarios. 
      a) Case of adjustable SHM program. 
        In this case  x=1, mt ≈ mtopt and Eq.11 can be further simplified to give: 
 
 PAM
adj =
exp −4 h
2
2σ 2 mtopt
⎧⎨⎩
⎫⎬⎭
2 hσ mt( )opt π
(15) 
 
The duration of SHM program decreases and the proportion of matured B-cells grows 
exponentially upon increase of initial antigen affinity, i.e. when G0 → Gc . This is 
probably the case when memory B cells exist for an incoming antigen. Experiment shows 
that the number of mutations  acquired in mouse model VH,L mt = mt( )opt ≈ 15 (Shih et al. 
2002). It is more difficult to estimate the parameter 
h2
2σ 2  for interactions between Ig and 
Ag. However a similar (in spirit) estimate from experimental data was made in 
(Zeldovich et al. 2007a)  for mutations affecting protein stability. Using these data as a 
rough approximation we get an estimate 
h2
2σ 2 ≈
1
6
 giving finally for the optimal size of a 
GC M ≈ 104  B cells which is roughly consistent with reality (MacLennan 1994) . (This 
is a rough estimate, because  (Zeldovich et al. 2007a) dealt with energetic effect of 
mutations on protein stability while this quantity concerns  the effect of mutations on free 
energy of interactions between Ag and Ig) 
         
        b) Case of preset SHM program (Shih et al. 2002) 
         In this case mt = const  regardless of which antigen is presented.   However the 
actual number of mutations accepted in matured B cells differs from the most probable 
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number of mutations mt due to post-SHM selection. The strength of selection can be 
quantified by parameter x = N
mt
 introduced above. This quantity can be obtained by 
solving Eq.10. (see Fig.8A). The initial affinity of germline Igs to antigen G0  
determines– the stronger initial affinity G0  is, the lower is mt( )opt  (see Eq.(4)).  The result 
is shown in Fig.8B. It is in agreement with experiment: presentation of higher affinity Ag 
(i.e. lower mtopt ) results in a smaller number of accepted mutations in selected B cells 
(Shih et al. 2002). However the observed decrease of the number of accepted mutations 
in VH,L genes when higher affinity antibodies are presented is also consistent with the 
possibility of adjustable SHM program because in this case the actual SHM program 
mt  varies to match mt( )opt  when various Ags are presented.  
 
Figure 8  Selection in a SHM program. (A) The number of mutations in selected mature 
cells  as a function of SHM rate. This number is normalized by average number of 
mutations, so that this figure highlights the role of selection. (B). The strength of 
selection depends on the affinity of the incoming Ag.  Lower  initial affinity (i.e. greater 
G0 ),  corresponds to a more extensive optimal SHM program (greater mt( )opt ) and 
increased number of accepted mutations (at a given fixed average number of attempted 
mutations mt ). A similar behavior is observed in experiment (Shih et al. 2002). The 
results of (A) and (B) are obtained from solution of Eq.(10) 
 
Why and when is SHM needed? 
At first glance the two-stage process where first Igs of moderate affinity G0  are selected 
and then they undergo additional round of mutations may seem redundant. Why not 
select (admittedly few) strongly binding Ags from a huge germline pool and clonally 
expand those without additional round of mutations? In other words an alternative 
scenario could be a formation of the same GCs, activation of moderate affinity 
centroblasts there so that each centroblast clonally expands into M copies but without 
SHM, i.e. all M centroblasts in any GC express the same Ig in this scenario (while 
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centroblasts of different GCs express different Igs) .  In order to determine which 
scenario is advantageous we compare the number of mature centroblasts (i.e. which 
express Ig with binding free energy to antigen stronger than Gc ) under each scenario. 
     In the first scenario (‘’one-shot’’ selection without SHM) the number of mature 
centroblasts is: 
 
 
 
N 1s Gc( )= MNg
2πΣ2 e
− G−Gav( )2
2Σ2
−∞
Gc∫ dG ≈ − MNgπ
Σ
Gc − Gav
e
− Gc −Gav( )2
2Σ2 (16) 
 
where we assumed that binding free energies between Ag and germline pool Igs are 
Gaussian distributed (Deeds et al. 2006; Lukatsky et al. 2007),  Ng  is the total number of 
B cells in germline pool.  Gav is average free energy of interactions between germline Igs 
and Ag and Σ  is the variance of free energy between Ag and Ig over all Igs in the 
germline pool.  
        In the two stage process involving SHM GC are established first in a ‘’one-shot’’ 
selection process i.e. by recruiting germline B cells expressing Igs with affinity exceeding 
a certain threshold value  G0 > Gc  and then centroblasts clonally expand to M cells in 
each GC, undergoing a  SHM  program.  
         The number of mature centroblasts obtained  under the 2-stage  SHM scenario   
is apparently: 
 
 
 
N AM
2s Gc( )= NGC MPAMadj Gc − G0( )≈ Ng M Σσ2 π G0 − Gav( )Gc − G0( )e
− Go −Gav( )2
2Σ2 e
2
Gc −G0( )h
σ 2       
(17) 
 
where NGC = N1s (G0 )  is the number of GCs formed and we assumed that SHM program 
is optimal –best case scenario for 2-stage selection . The probability
 
PAM
adj Gc − G0( )is 
given by Eq.(15) and its dependence on Gc − G0  is through mt( )opt   according to 
Eqs.(4,5). The system has flexibility in the choice of the affinity threshold G0  at which to 
activate SHM program. An optimum with respect to the choice of  G0  is achieved at:  
 
 G0
opt = Gav − 2h Σ
2
σ 2        (18) 
 
Substituting (18) into (17) we obtain maximal possible efficiency of the 2-stage program  
of development of potent B cells  via clonal selection and affinity maturation: 
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N AM
2s( )
max
= − σ
3Ng M
4 π hΣ Gc − Gav + 2h Σ
2
σ 2
⎛
⎝⎜
⎞
⎠⎟
e
2h2
σ 2
Gc −Gav
h
+ Σ
2
σ 2
⎡
⎣
⎢⎢
⎤
⎦
⎥⎥         (19) 
 
The two-stage program is advantageous over one-shot selection when G0
opt > Gc , i.e. 
when    
                             
           Gc < Gav − 2h Σ
2
σ 2                (20) 
 
The main result of our theory,  Eq.19 is noteworthy. First, it shows that the number of 
mature B cells decays exponentially with respect to the maturation threshold Gc . This 
immediately implies that there is a ceiling in affinity of matured BCRs achieved when 
 N AM
2s ≤ 1 , Such ceiling was indeed observed in experiments (Batista and Neuberger 
1998). Second, the theory predicts that greater diversity of Ab interactions in the germline 
pool Σ( ) is advantageous for selection of potent antibodies.  However this consideration 
should be balanced against possible detrimental effect of promiscuity of Ab interactions 
including autoimmunity effect (Sun et al. 2005) . The analysis of the balance between 
affinity maturation and autoimmunity is a subject for future study.  
       Finally, our theory provides insight into the fate of B cells in response to incoming 
antigens. The affinity of most incoming Ags to germline Immunoglobulins is close to Gav  
(which depends on incoming antigen).  Our result Eq.20 shows that SHM is efficient and 
necessary only when germline Igs exhibit relatively low affinity to the incoming Ag. (i.e. 
when Gav − Gc  is large enough.). In the opposite case when incoming Ags already have 
substantial affinity to germline Igs,  differentiation and direct clonal expansion of potent 
B cells in germline pool is advantageous. Remarkably, it appears that Nature follows 
similar considerations. (Hangartner et al. 2006). 
     A more quantitative analysis of the results of presented theory requires a systematic 
study of sequence diversity and energetics of interactions between germline and mature 
Igs  and various Ags (Tomlinson et al. 1996; Chen et al. 1999; Clark et al. 2006) which 
will be addressed in future studies.  
Controls: What is important for effective immune response? 
Our model of immune response is minimalistic yet it contains a number of  assumptions 
such as Ag and ‘’self-interaction’’ (autoimmunity) dependent activation of B-cells. 
Importantly and in contrast with earlier models (e.g. (Pierre et al. 1997)) our model 
explicitly considers proteins stability. By requiring that potent Ig and viral proteins must 
be stable in their native conformations our model introduces competition and interrelation 
between folding and binding. In order to understand the effect of each of those 
requirements we ran control simulations whereby individual assumptions of the model 
were relaxed one by one and their impacts on various aspects of immune response in the 
model were examined. (Table I). Apparently activation is crucial for effective immune 
response – removal of the dependence of duplication rate of B cells on Ag affinity results 
in deteriorated immune response. In contrast selection against autoimmunity imposes a 
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strict constraint on efficiency of immune response by dramatically decreasing the 
probability of the healing outcome.  
     Our simulations revealed a specific mechanism of evolution of potent Igs in response 
to mutating viral Ag. In particular we found that mature Igs are progenitors of a small 
subset of naïve cells which exhibited initial affinity to the incoming Ag higher than 
certain threshold (‘’Monoclonality’’) despite the fact that sequence diversity of matured 
Ig’s is significant (see Fig.6), in agreement with experiment (Jacob et al. 1991). 
Interestingly, we find that the physical reason for monoclonality of evolved potent Igs in 
simulations is in the interplay between Ig stability and its affinity to the antigen. Indeed 
when the requirement of Ig stability is relaxed in control simulations the mechanism 
changed dramatically – ‘’monoclonality’’ is lost, potent Igs are now ancestors of a broad  
variety of germline Igs and activation times (the number of time steps to achieve mature 
Igs) drop dramatically. We conclude that interplay between folding and binding shapes 
the search in sequence space of Igs in a crucial way. Consequently, relaxation of 
requirement for Ig proteins to be stable leads to much greater polyclonality and sequence 
diversity of mature Igs.  
 
Immunoglobulin Virus 
Full Model 
w/o stability w/o activation w/o autoimmunity w/o stability  
H P H P H P H P H P 
Percentage 
probability 48.5 21.0 52.0 48.0 1.0 1.0 88.5 11.5 23.5 49.0 
Monoclonality 0.79 0.78 0.16 0.17 0.06 0.04 0.80 0.83 0.77 0.86 
<Pint(Ig,v)> 
(stdev) 
0.54 
(0.10) 
0.51 
(0.12) 
0.41 
(0.18) 
0.40 
(0.18) 
0.17 
(0.07) 
0.15 
(0.05) 
0.55 
(0.11) 
0.60 
(0.13) 
0.54 
(0.10) 
0.54 
(0.11) 
Sequence 
diversity 0.49 0.43 0.70 0.70 0.47 0.45 0.77 0.61 0.55 0.44 
Activation  
time 173 184 55 52 36 20 268 204 234 177 
 
 
Table 1. Control simulations where various constraints of the immunity model have been 
relaxed. 200 independent simulations are performed at mv=0.0003 and mIg=0.08 for each 
control case. H and P respectively represent healing and persistent infection pathways. 
Monoclonality (or monoclonal selectivity) is defined as the maximum fraction of the 
activated “red antibodies” which are averaged over all pathways of healing or persistent 
infection. <Pint(Ig,v)> is the averaged protein-protein interaction strength between Ig 
and virus protein, and the numbers in parenthesis are standard deviations of Pint(Ig,v). 
The sequence diversity is averaged sequence entropy of antibodies when the activated 
“red antibodies” first achieve the maximum fraction of the antibody pool of system 
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during simulation. The activation time is the elapsed time for the activated “red 
antibodies” to achieve the maximum fraction pool from the first viral infection. 
 
Conclusions  
We presented a microscopic bottom-up model of immunity in an interacting host-
pathogen system. A complex interplay between genetics, physics of proteins, and 
population dynamics provides a rich variety of dynamical regimes, identifying all 
possible outcomes such as healing, host extinction, and persistent infection as a function 
of the mutation and replication rates. The presented diagram of the infection outcomes as 
function of the mutation rates can be of interest for the development of therapeutic 
approaches to certain diseases.  
              Perhaps the most striking result of our study is that two stage immune response 
of clonal selection and affinity maturation exactly as postulated by Burnet has emerged 
from simulations in a purely microscopic model which did not postulate a’priori any 
mechanism. Importantly, we showed that the Burnet’s mechanism is a consequence of 
delicate balance between search and selection of high affinity antibodies and the need to 
maintain their stability as folded proteins. As a result sequence evolution of Ig proteins 
included initial selection of moderately binding germline molecules and their subsequent 
clonal amplification accompanied by affinity maturation (Jacob et al. 1991). As our 
control shows, neglect of stability factor dramatically changes the dynamics of affinity 
maturation leading to highly polyclonal Ig molecules (our model corresponds to 
development of just one GC). However, we stress here that monoclonality of emerged Ig 
molecules does not result in their sequence homogeneity – significant sequence variation 
of matured Ig molecules is observed both in our model and in reality  (MacLennan 1994).   
      The analysis of affinity maturation in simulations motivated us to develop an 
analytical theory of affinity maturation.  Its key insight is a non-trivial quantitative 
relation between molecular properties of individual V domain genes in centroblasts - such 
as the number of acquired mutations (Jacob et al. 1991) and their energetic impact– and 
the number of generations of centroblast expansion in GC required to achieve successful 
AM. Our results on dynamics of affinity maturation are in excellent quantitative 
agreement with experimental observations, despite simplicity of the model and theory. In 
our simulations Ig molecules accrue in average 5 mutations during their affinity 
maturation process while in reality it is closer to mt=10-15 mutations (Shih et al. 2002). 
This can be expected because our model proteins are smaller than V domains of Ig.  We 
assume that SHM program operates close to optimal. The estimate 
h = 1kcal / m and σ 2 = 3 kcal / m( )2  for the parameters of the model comes from the 
analysis on impact of point mutations on protein stability (Zeldovich et al. 2007a).  Eq. 
13 then predicts that upon completion of the SHM program  the fraction of mature B-cells 
in the pool is PAM = 10−4 ÷10−5  (the variation is due to uncertainty in the experimental 
estimates of the number of mutations in VH,L  (Shih et al. 2002) (Jacob et al. 1991)). 
Therefore our theory predicts that  B cells should expand in GC to population of 
104 ÷105  in order to ensure successful AM. Again this number is entirely consistent with 
reality: cell cycle of centroblasts is about 6 hrs (MacLennan 1994), though a longer time 
closer to 12hrs has been suggested recently (Allen et al. 2007), and the SHM rate is 
roughly 1 mutation per V domain per generation (Kleinstein et al. 2003). Observed 
number of mutations is therefore accrued in 15 generations (4-6 days) - exactly the time 
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frame to generate 104 ÷105  B cells (MacLennan 1994; Or-Guil et al. 2007). This 
analysis shows that AM is likely to be a ‘’one-pass’’ process in each GC.  Perelson  and 
coworkers argued that a ‘’one-pass’’  AM is hardly efficient (Oprea et al. 2000). 
However their mathematical model is based on a number of assumptions (e.g two affinity 
classes, no post-SHM expansion in LZ).  In contrast, here we consider a continuum of 
mutation effects in a physically realistic model of protein-protein interactions, not just 
two affinity classes. Further, we note that AM is successful even when few B cells 
expressing sufficiently potent Igs appear in the pool after SHM. They can differentiate 
into plasma cells and expand (Phan et al. 2006). Our analysis shows that an optimal SHM 
program depends dramatically on the initial affinity of  Igs at the start of the program 
(parameter G0 , see Eq.4). This means that for multiple round SHM to be efficient, the 
SHM program should adjust at every round as Igs of higher affinity progressively evolve. 
While not impossible, there is no experimental evidence that such adjustments take place. 
Without them, however, the progressive rounds of SHM of fixed length may quickly 
become detrimental as they would subject evolving potent Igs to multiple rounds of 
random destabilizing mutations. 
       (Shih et al. 2002) argued that SHM program is fixed in an organism. Our theory 
predicts that optimal program – the average number of attempted mutations – depends on 
two affinity thresholds for T-dependent B cell activation – the first (at affinity G0 ) is 
when resting B cells are activated to enter the response, and the second ( Gc ) which 
selects those somatically mutated Immunoglobulines which acquired sufficient affinity to 
the Ag for differentiation into plasma and/or memory cells. It is likely that each organism 
establishes these thresholds so that it can run an optimal SHM program. However a 
fraction of germline B cells may express potent antibodies with binding energy to 
incoming Ag below threshold value  G0 . In this case it could be detrimental for these B 
cells to enter SHM program. Rather these B cells undergo extrafollicular plasma cell 
differentiation without SHM (Paus et al. 2006; Phan et al. 2006).  An interesting recent 
observation suggests that indeed SHM may be individually tuned in each organism and 
that such tuning depends on relationship between affinity of germline Igs and mature Igs 
as predicted by this theory. It was shown in (Dooley et al. 2006) that in ectothermic 
vertebrates (sharks) the initial affinity  of IgNAR is very high – KD in low nm; however 
affinity maturation is short (sharks lack Germinal Centers) and improves affinity only an 
order of magnitude, while in vertebrates initial affinity is weak – in millimolar to 
micromolar range - but affinity maturation improves KD  1000 fold or more (De Genst et 
al. 2004; Dooley et al. 2006).  Shorter affinity maturation in shark compared to 
vertebrates is related to slower rate of   their B cell replication, however it is compensated 
by high rate of the initial IgNAR mutation to create an extremely diverse initial germline 
pool that contained highly potent antibodies.  Our theory predicts exactly that – that 
diversity of Ag-Ig interactions in the germline pool (parameter Σ  in Eqs(17-20)) is a 
major determinant of the duration and depth of the SHM program (e.g. see Eq.20). 
      Our simulations show, paradoxically, that cytopathic viruses evolve to have mild 
affinity to germline Igs. Indeed as shown in Figure 5 mutating viruses acquire selective 
advantage by developing moderate binding to germline Igs of the organism (in 
simulations shown in Fig.5 we kept Ig mutation rate at 0). This compromise helps 
coexistence as neither party eliminates the other one. Interestingly a similar behavior is 
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observed for natural cytopathic viruses (e.g VSV in mice) – in this case the defense is 
realized mostly due to significant affinity of viral antigens to germline Igs of the host 
organism without affinity maturation (Hangartner et al. 2006).  What about SHM 
response in this case when incoming antigens have strong affinity in average to most 
germline BCR? The theory predicts that in this case (high Gav  in Eq.18) the ‘’one-shot’’ 
selection where potent Igs are directly selected from the germline pool is a winning 
strategy. Experiment shows that this is indeed the case: infection with highly cytopathic 
VSV virus induces direct response from the germline without much affinity maturation 
while infection with poorly cytopathic viruses (LCMV in mice, HCV,HBV in humans)  
induces a response which includes affinity maturation via SHM (Kalinke et al. 1996; 
Hangartner et al. 2006). 
      An important aspect of our microscopic model is consideration of autoimmunity 
which significantly restricts possible scenarios of sequence evolution of Ig. While real 
organisms defend themselves against autoimmunity through a complex process of clonal 
elimination of helper T-cells in the thymus  (Kappler et al. 1987) , here we model it in a 
coarse-grained way by postulating that B-cell activation is restricted when 
Immunoglobulins which they produce attack the organism’s own antigens. While the 
process of T-cell maturation is not yet fully understood, this coarse-grained description 
captures its essence without introducing T-helpers explicitly in the model. Deem and 
coworkers suggested that cross-reactivity significantly affects affinity maturation 
dynamics (Sun et al. 2005). Our simulations are in agreement with this proposal. Indeed 
as can be seen in Table I autoimmunity significantly constrains the sequence repertoire of 
emerging Igs and removing autoimmunity requirements shifts the likely infection 
outcome from persistent infection to healing even for highly mutating viruses.  
        Quantitatively, our model suggests that in the healing regime the optimal mutation 
rate of an antibody should be about 103 higher than that of a virus. This finding is 
generally in agreement with experiment: the SHM rate is about 10-3 per bp per division 
(Kleinstein et al. 2003), while DNA viruses have a much lower mutation rate, 10-6 to 10-8 
per bp per replication, at least three orders of magnitude lower (Drake et al. 1998). RNA 
viruses, however, have much higher mutation rates (Drake and Holland 1999), and, 
according to the model, may often cause a persistent infection. Quite remarkably the 
optimal Ig mutation rate observed here almost exactly coincides with estimates for SHM 
in natural Immunoglobulins  (see Fig.S3 in Supporting Information). 
          This model provides a unique opportunity to glean insights into evolution of 
adaptive immunity by highlighting bare bone minimal requirements for a functional 
adaptive immune response. Our assumptions here are simple: an interaction between 
organism’s defensive proteins (Igs) and viral antigen 1) imparts viral ability to grow and 
2) affects the rate at which Ig producing B cells divide (activation). While the first 
assumption is mechanistic and almost trivial, the second one, being crucial for the model 
to work (see Table I), is not so ‘’evolutionary innocent’’.  Indeed the specific molecular 
mechanism by which affinity to antigen affects the fate of B cells, especially their 
apoptosis and T-cell dependent expansion is elusive (Batista and Neuberger 1998; 
McHeyzer-Williams et al. 2006). Our results suggest that evolutionary discovery of such 
feedback mechanism had been the key punctuated step towards adaptive immunity. It 
would be extremely interesting to get further insights from phylogenomics of how such 
mechanism emerged and what are its precursors in invertebrates. 
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          Earlier theoretical studies of many aspects of immune response, including affinity 
maturation, treated protein thermodynamics and interactions within simplified 
phenomenological frameworks. A ‘’string approximation’’ which does not consider 
protein stability and treats interacting surfaces as superimposed short strings of simplified 
amino acids – ‘’characters’’ with simple ‘’matching rules’’ to approximate interaction 
energetics was used in (Celada and Seiden 1996; Pierre et al. 1997). Another widely used 
approximation is Kauffman’s NK model which presents various contributions to protein 
stability and interactions as independent random quantities (Kauffman and Weinberger 
1989). Although these models are useful as  first approximations, their generic limitation 
is that the properties of proteins are not derived from their sequences. However evolution 
of potent antibodies amounts to improving their affinity to an antigen while keeping them 
from attacking the organism’s own proteins (autoimmunity) and retaining their stable 
structure. This delicate balancing act has to be accomplished via sequence search. 
Therefore the basic principles of adaptive immunity can be consistently addressed only in 
sequence-based models which explicitly derive Ig stability and interactions from their 
sequences using a physically realistic energetics of intra- and intermolecular interactions. 
The physical realism of energetics is an important issue. While string matching models 
assume linear arrangement of amino acids on the interface and that each amino acid 
should have a unique partner in a potent interface, in reality interaction energy is a sum of 
many relatively weak contributions, which can be realized, for each amino acid, by 
diverse and multiple interaction partners (Janin and Seraphin 2003; Bahadur et al. 2004; 
Bordner and Abagyan 2005; Lukatsky et al. 2007). This fundamental property of 
interactions in proteins gives rise to significant plasticity in sequence space which 
crucially affects sequence evolution of Igs via development of neutral networks  
(Bornberg-Bauer and Chan 1999; Zeldovich et al. 2007b). While our model is coarse-
grained, it certainly captures these key aspects of proteins, providing insights into 
evolution and selection of potent Ig sequences. Most importantly, the combination of ab 
initio simulation with analytical theory helps to get better understanding of robust 
principles of adaptive immunity. In particular we found that SHM is a sensitive 
mechanism which may be effective only under certain well-defined conditions, such as 
affinity range of incoming antigens (Hangartner et al. 2006; Paus et al. 2006). There is 
significant evidence that Nature indeed employs SHM selectively only when conditions 
are conducive to productive SHM program. The molecular mechanism which helps B 
cells to react selectively to incoming antigens  is not clear yet. 
       Our model is still quite minimalistic.  Its particular molecular mechanisms here are 
quite schematic and may differ significantly from actual biological pathways that are 
operational in living cells. In particular we do not explicitly model the important role of 
helper T-cells in B-cell activation. Rather we assume this mechanism in a coarse-grained 
fashion by postulating a certain relationship between B-cell replication rate and affinity 
of their Ig to an antigen. Further the spatial dynamics aspects are completely disregarded 
here – perhaps this factor leads to exaggerated effects in populations of viruses and cells 
showing a dramatic drop in population sizes at the healing bottleneck (Fig.3). However 
this aspect of the present model is less realistic as it does not treat tissues as real 3D 
objects where proliferation of infection is limited by diffusion. Another limitation of this 
study is lack of consideration of dosage and memory effects. This can be done in the 
present model by introducing concentrations of antigens and Igs and using the law of 
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mass action to estimate binding, although this refinement goes beyond the scope of this 
paper (work in progress). Despite these limitations, the striking qualitative and 
quantitative similarity of the general features of immune response found in this model to 
natural defense mechanisms attest to the robustness of physical principles of adaptive 
immunity. Quite complicated machinery evolved to realize these physical principles in 
jawed vertebrates. Our simulations first and foremost show an amazing power of 
evolution where a blueprint for a very complex function is provided by physical 
principles while its execution is brilliantly carried out via mutation and natural selection 
processes as postulated by Darwin long ago. 
 
Model and Methods 
 The model (see Figure 1, and Supplementary Information for details) consists of 
three types of entities, each with its own population dynamics: host cells, 
Immunoglobulins (antibodies) and viruses. Each host cell, antibody, and virus are 
modeled individually by keeping track of their protein sequences. Proteins are modeled as 
27-unit compact polymers, so that their thermodynamic properties, stability and 
interaction can be calculated exactly from their primary sequences (More details are in 
Supplementary Information and in (Zeldovich et al. 2007b)). A genome of each host cell 
consists of three genes. The replication rate of cells is constant, and the (intrinsic) death 
rate of  host cells is determined by stability of its proteins as in (Zeldovich et al. 2007b).  
Each virus carries one protein (antigen); once a virus infects a host cell, the virus starts to 
replicate at a rate, bv, dependent on the stability of viral protein and the interaction 
strength between viral and Ig proteins. 
  
 
 
bv = b0v ⋅ Pnat (v) ⋅ 1− Pint ( Ig,v)( ), (21) 
 
where b0v is a viral replication rate constant, Pnat(v) is protein stability of virus (i.e. 
Boltzmann probability for the virus protein to be in its native conformation), and Pint(Ig,v)  
is Boltzmann probability of a specific interaction between Ig protein and virus protein 
which serves as a measure of their interaction strength (see Supplementary Text for exact 
definition of this quantity) . Strong binding inhibits virus replication. We model 
cytophatic visruses which may destroy host cells via lysis. Once the number of viruses in 
a given cell exceeds the lysis threshold, the cell dies and releases the viruses that can 
further infect uninfected cells. If free viral particles cannot find any host cell within a 
certain time, they are removed. The replication rate of antibodies bIg is determined by 
interaction between Ig and viral proteins if the cell is infected (strong binding increases 
antibody replication rate), and the autoimmunity effect (strong binding between Ig and a 
functional protein decreases the replication rate),  
 
 
 
bIg = b0Ig[1+αPint ( Ig,v)] ⋅ 1− maxi Pint ( Ig,gi )⎡⎣ ⎤⎦ , (22) 
 
where Pint(Ig,gi) and Pint(Ig,v) are respectively the Ig protein’s interaction strength  with i-
th protein of the cell and a randomly chosen viral particle in the cell. The index i runs 
from 1 to 3. In the context of the immune system, an increase of antibody replication rate 
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with the antigen binding strength is a well-known phenomenon of B-cell activation by an 
antigen  (MacLennan 1994; Rajewsky 1996; McHeyzer-Williams et al. 2006)  .  
Upon division of an infected cell, viruses are randomly distributed between its 
two off-springs, and when an infected cell dies, any viruses it contains are also removed 
from the population. The simulation ensemble consists of up to 5000 completely 
independent cells, 20000 independent virus particles, and 8000 antibodies, mutating and 
replicating according to the above rules. If necessary, cell population is clipped at 5000, 
simulating a chemostat, and the antibody population is clipped at 8000. The mutation rate 
of Ig proteins is set significantly above that of functional proteins, mimicking SHM 
observed in B-cells , and the mutation rate of viruses is also higher than the normal host 
protein mutation rate. For the initial 1500 evolutionary time steps, host cell genes and 
antibodies are allowed to evolve with mutation rates mcell=mIg=0.05 per protein per time 
step to equilibrate their protein sequences, and then the mutation rates drop to mcell 
=0.0001 and mIg=0.005 (see Supplementary Information for details). At t=2001, one 
thousand of identical free viruses are introduced into the system, starting the infection.  In 
order to evaluate how mutation rates of Ig genes and viruses affect the outcome of cell-
virus competition, we run multiple simulations with different mutation rates of viruses 
and Ig genes while keeping mutation rates of host cell’s genes fixed as described above.  
 
 
Acknowledgememts. This work is supported by the NIH. We thank Michael Deem for 
valuable comments on the manuscript. 
 
 27
 
 
References 
 
Allen CD, Okada T, Cyster JG (2007) Germinal-center organization and cellular 
dynamics. Immunity 27(2): 190-202. 
Bahadur RP, Chakrabarti P, Rodier F, Janin J (2004) A dissection of specific and non-
specific protein-protein interfaces. Journal of molecular biology 336(4): 943-955. 
Batista FD, Neuberger MS (1998) Affinity dependence of the B cell response to antigen: 
a threshold, a ceiling, and the importance of off-rate. Immunity 8(6): 751-759. 
Berek C, Berger A, Apel M (1991) Maturation of the immune response in germinal 
centers. Cell 67(6): 1121-1129. 
Bordner AJ, Abagyan R (2005) Statistical analysis and prediction of protein-protein 
interfaces. Proteins 60(3): 353-366. 
Bornberg-Bauer E, Chan HS (1999) Modeling evolutionary landscapes: mutational 
stability, topology, and superfunnels in sequence space. Proc Natl Acad Sci U S A 
96(19): 10689-10694. 
Burnet F (1959) The Clonal Selection Theory of Acquired Immunity. Cambridge: 
Cambridge University Press. 
Celada F, Seiden PE (1996) Affinity maturation and hypermutation in a simulation of the 
humoral immune response. European journal of immunology 26(6): 1350-1358. 
Chen G, Dubrawsky I, Mendez P, Georgiou G, Iverson BL (1999) In vitro scanning 
saturation mutagenesis of all the specificity determining residues in an antibody 
binding site. Protein engineering 12(4): 349-356. 
Clark LA, Ganesan S, Papp S, van Vlijmen HW (2006) Trends in antibody sequence 
changes during the somatic hypermutation process. J Immunol 177(1): 333-340. 
De Genst E, Handelberg F, Van Meirhaeghe A, Vynck S, Loris R et al. (2004) Chemical 
basis for the affinity maturation of a camel single domain antibody. The Journal 
of biological chemistry 279(51): 53593-53601. 
Deeds EJ, Ashenberg O, Shakhnovich EI (2006) A simple physical model for scaling in 
protein-protein interaction networks. Proc Natl Acad Sci U S A 103(2): 311-316. 
Dooley H, Stanfield RL, Brady RA, Flajnik MF (2006) First molecular and biochemical 
analysis of in vivo affinity maturation in an ectothermic vertebrate. Proc Natl 
Acad Sci U S A 103(6): 1846-1851. 
Drake JW, Holland JJ (1999) Mutation rates among RNA viruses. Proc Natl Acad Sci U 
S A 96(24): 13910-13913. 
Drake JW, Charlesworth B, Charlesworth D, Crow JF (1998) Rates of spontaneous 
mutation. Genetics 148(4): 1667-1686. 
Eisen HN, Siskind GW (1964) Variations in Affinities of Antibodies During the Immune 
Response. Biochemistry 3: 996-1008. 
Elena SF, Lenski RE (2003) Evolution experiments with microorganisms: the dynamics 
and genetic bases of adaptation. Nat Rev Genet 4(6): 457-469. 
Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: the 
two extremes of a wide spectrum. Nature reviews 6(3): 231-243. 
Jacob J, Kelsoe G (1992) In situ studies of the primary immune response to (4-hydroxy-
3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid 
 28
sheath-associated foci and germinal centers. The Journal of experimental 
medicine 176(3): 679-687. 
Jacob J, Kelsoe G, Rajewsky K, Weiss U (1991) Intraclonal generation of antibody 
mutants in germinal centres. Nature 354(6352): 389-392. 
Janin J, Seraphin B (2003) Genome-wide studies of protein-protein interaction. Current 
opinion in structural biology 13(3): 383-388. 
Kalinke U, Bucher EM, Ernst B, Oxenius A, Roost HP et al. (1996) The role of somatic 
mutation in the generation of the protective humoral immune response against 
vesicular stomatitis virus. Immunity 5(6): 639-652. 
Kappler JW, Roehm N, Marrack P (1987) T cell tolerance by clonal elimination in the 
thymus. Cell 49(2): 273-280. 
Kauffman SA, Weinberger ED (1989) The NK model of rugged fitness landscapes and its 
application to maturation of the immune response. Journal of theoretical biology 
141(2): 211-245. 
Kleinstein SH, Louzoun Y, Shlomchik MJ (2003) Estimating hypermutation rates from 
clonal tree data. J Immunol 171(9): 4639-4649. 
Liu YJ, Johnson GD, Gordon J, MacLennan IC (1992) Germinal centres in T-cell-
dependent antibody responses. Immunology today 13(1): 17-21. 
Lukatsky DB, Shakhnovich BE, Mintseris J, Shakhnovich EI (2007) Structural similarity 
enhances interaction propensity of proteins. Journal of molecular biology 365(5): 
1596-1606. 
MacLennan IC (1994) Germinal centers. Annual review of immunology 12: 117-139. 
McHeyzer-Williams LJ, Malherbe LP, McHeyzer-Williams MG (2006) Checkpoints in 
memory B-cell evolution. Immunological reviews 211: 255-268. 
Mehr R, Edelman H, Sehgal D, Mage R (2004) Analysis of mutational lineage trees from 
sites of primary and secondary Ig gene diversification in rabbits and chickens. J 
Immunol 172(8): 4790-4796. 
O'Connor BP, Vogel LA, Zhang W, Loo W, Shnider D et al. (2006) Imprinting the fate of 
antigen-reactive B cells through the affinity of the B cell receptor. J Immunol 
177(11): 7723-7732. 
Oprea M, van Nimwegen E, Perelson AS (2000) Dynamics of one-pass germinal center 
models: implications for affinity maturation. Bulletin of mathematical biology 
62(1): 121-153. 
Or-Guil M, Wittenbrink N, Weiser AA, Schuchhardt J (2007) Recirculation of germinal 
center B cells: a multilevel selection strategy for antibody maturation. 
Immunological reviews 216: 130-141. 
Paus D, Phan TG, Chan TD, Gardam S, Basten A et al. (2006) Antigen recognition 
strength regulates the choice between extrafollicular plasma cell and germinal 
center B cell differentiation. The Journal of experimental medicine 203(4): 1081-
1091. 
Phan TG, Paus D, Chan TD, Turner ML, Nutt SL et al. (2006) High affinity germinal 
center B cells are actively selected into the plasma cell compartment. The Journal 
of experimental medicine 203(11): 2419-2424. 
Pierre DM, Goldman D, Bar-Yam Y, Perelson AS (1997) Somatic evolution in the 
immune system: the need for germinal centers for efficient affinity maturation. 
Journal of theoretical biology 186(2): 159-171. 
 29
Rajewsky K (1996) Clonal selection and learning in the antibody system. Nature 
381(6585): 751-758. 
Roost HP, Bachmann MF, Haag A, Kalinke U, Pliska V et al. (1995) Early high-affinity 
neutralizing anti-viral IgG responses without further overall improvements of 
affinity. Proc Natl Acad Sci U S A 92(5): 1257-1261. 
Shih TA, Meffre E, Roederer M, Nussenzweig MC (2002) Role of BCR affinity in T cell 
dependent antibody responses in vivo. Nature immunology 3(6): 570-575. 
Sun J, Earl DJ, Deem MW (2005) Glassy dynamics in the adaptive immune response 
prevents autoimmune disease. Phys Rev Lett 95(14): 148104. 
Tomlinson IM, Walter G, Jones PT, Dear PH, Sonnhammer EL et al. (1996) The imprint 
of somatic hypermutation on the repertoire of human germline V genes. Journal of 
molecular biology 256(5): 813-817. 
Zeldovich KB, Chen P, Shakhnovich EI (2007a) Protein stability imposes limits on 
organism complexity and speed of molecular evolution. Proc Natl Acad Sci U S A 
104(41): 16152-16157. 
Zeldovich KB, Chen P, Shakhnovich BE, Shakhnovich EI (2007b) A First-Principles 
Model of Early Evolution: Emergence of Gene Families, Species, and Preferred 
Protein Folds. PLoS Comput Biol 3(7): e139. 
 
 
 30
Supplementary Text 
 
Methods 
 
Protein model: Stability and interactions 
 
 We consider a 3x3x3 lattice protein as a model protein in order to calculate 
thermodynamic quantities such as protein stability and protein interaction strength 
exactly (Shakhnovich 1990; Zeldovich et al. 2007). To save computer time, we reduce 
protein structural space from 103,346 structures to randomly and uniformly chosen 
10,000 structures. Each protein folds into the native structure which has minimum energy 
out of 10,000 structures. Protein stability is calculated in terms of the Boltzmann 
probability (Pnat) of the native (i.e. lowest energy) structure of the protein at given 
temperature, 
 
 
 
Pnat (g,T ) =
exp −E0(g) / T⎡⎣ ⎤⎦
exp −Ei (g) / T⎡⎣ ⎤⎦
i=1
10000∑
, (S1) 
 
where g is a protein sequence in 20 amino acid type alphabet, E0(g) and Ei(g) are energies 
of protein in the native and i-th structure respectively, and T is an environmental 
temperature. In order to calculate interaction strength between two proteins, we consider 
rigid-body docking between two 3x3x3 lattice proteins. Each lattice protein has six 
binding surfaces and four-fold rotational symmetry of a binding surface (only the 
strongest binding positions when two faces overlap completely making 9 interaction 
bonds are taken into account. (see Figure S1) Therefore, a pair of lattice proteins has 
6x6x4 binding conformations. Protein interaction strength is defined by the Boltzmann 
probability (Pint) of the specific binding between two protein g1 and g2 as following. 
 
 
 
Pint (g1,g2 ) =
exp − f ⋅ E0(g1,g2 ) / T⎡⎣ ⎤⎦
exp − f ⋅ E j (g1,g2 ) / T⎡⎣ ⎤⎦
j=1
144∑
, (S2) 
 
where E0(g1, g2) is the binding energy of two proteins in the binding mode corresponding 
to lowest energy out of all 144 possible binding modes, and f is a pre-factor that takes 
into account possible different strengths of intra-protein and inter-protein interactions. 
We use the Miyazawa-Jernigan pairwise contact potential for both protein structural and 
interaction energies (Miyazawa and Jernigan 1996), but scale protein-protein interactions 
by a constant factor. We chose T = 0.85 in Miyazawa-Jernigan potential dimensionless 
energy units and set f = 1.5. 
 
Cell dynamics; reproduction, death 
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We use here a simple model of host cells cell whose population dynamics is 
described by genetic information encoded in its genome. The genome of a cell consists of 
three genes, whose protein stability governs death rate the host cells. We connect the 
minimum stability of any protein in a cell to its death rate d as follows (Zeldovich et al. 
2007): 
 
 
 
d = d0 1− mini Pnat (gi )⎡⎣ ⎤⎦ , (S3) 
 
where d0 is a cell death rate constant and Pnat(gi) is gi protein’s stability and index i runs 
from 1 to 3. These cells also replicate at a constant rate. 
 
The immune system; immunoglobulin (Ig) dynamics 
 
For simplicity, we coarse-grain the complex processes of antigen recognition, B-
cell activation, and antibody production into the production rate of Ig proteins, 
determined by their physical interactions with the antigen (virus) and host cell proteins. 
The interaction between Ig protein and viral protein is responsible for the molecular 
recognition and suppression of the spread of exogenous toxic materials. Once an 
organism is infected by a virus, it can obtain immunity against the virus by increasing the 
strength of interaction between Ig and  viral RNA or enzymes. Also, the Ig protein should 
recognize “self” genes from “non-self” genes. If it mistakes “self” proteins for “non-self” 
proteins and binds them strongly, it suppresses the function of cellular proteins. This is 
the main cause of autoimmunity, and Ig’s evolution to avoid autoimmune disease. We 
mimic this by incorporating the protein interaction strength between Ig and normal 
proteins of the cell to the replication rate of Ig, which is written as follows. 
 
 
 
bIg = b0Ig ⋅ 1− maxi Pint ( Ig,gi )⎡⎣ ⎤⎦ , (S4) 
 
where b0Ig is an Ig protein’s replication rate constant and Pint(Ig,gi) is the interaction 
strength between Ig and i-th normal protein in the cell and index i runs from 1 to 3. The 
presence of antigens activates the antigen-specific B-cell’s differentiation into plasma 
cells to elevate the load of antibodies matching the antigens. The amplification of the 
antigen-specific B-cell differentiation is described by effective activation which results in 
enhanced the replication rate of B cells that produce antibodies with high specificity to 
the antigens. The infection by virus modifies the replication rate of antibody-producing 
B-cells (and therefore the rate of effective ‘’replication’’ of Ig proteins) as follows: 
 
 
 
bIg = b0Ig ⋅ 1− maxi Pint ( Ig,gi )⎡⎣ ⎤⎦ ⋅ 1+α ⋅ Pint (Ig,v)⎡⎣ ⎤⎦ , (S5) 
 
where Pint(Ig,v) is Ig protein’s interaction strength with viral particle in the system and α 
is antibody activation factor by antigens. Ig proteins suppress viral replication only when 
they reside in infected cells.  Ig proteins can be either bound to a viral protein within a 
host cell, or remain free. The replication rate of the free Ig proteins is determined by 
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calculating their interaction strength with a randomly chosen viral protein for Pint(Ig,v) 
and also randomly chosen cell for max Pint(Ig,gi). Free Ig proteins have no direct effect on 
the population dynamics of host cells and viruses; at each simulation step, a free Ig can 
penetrate an infected host cell and bind to one of the infecting viruses. Bound Ig cannot 
escape from the cells; upon division of an infected host cell, viruses together with any 
bound Ig are randomly distributed between the daughter cells. When an infected host cell 
dies, any Ig proteins it contained are removed. An Ig protein can fold and has 
functionality when its stability Pnat  (see Eq.S1) is greater than 0.4 in the model. 
Mutations which decrease Ig stability Pnat  below 0.4 lead to the “death” (removal) of the 
corresponding antibody. 
 
Virus dynamics, replication and lysis 
 
 A viral particle carries a single protein (antigen), denoted by v. A free viral 
particle can infect a cell which is unoccupied by other viral particles with viral infection 
rate. This particle can be mutated or replicated only when it resides in an infected host 
cell. Free viral particles are quickly removed when they fail to find their host cells. When 
the number of viral particles in a living host cell exceeds the lysis threshold, the viral 
particles induce lysis of the cell and are released. The replication rate of the virus is 
regulated by its protein stability and protein interaction strength with Ig protein. A viral 
replication rate bv can be written as following. 
 
 
 
bv = b0v ⋅ Pnat (v) ⋅ 1− Pint (Ig,v)⎡⎣ ⎤⎦ , (S6) 
 
where b0v is a viral replication rate constant, Pnat(v) is stability of the viral protein, and 
Pint(Ig,v) is protein interaction strength between Ig and viral protein.  
 
Simulations 
 
 Initially 100 cells with 3 identical primordial genes and 100 identical Ig proteins 
are seeded in the system. Initial simulation starts with same cell division rate b, cell death 
rate d, and Ig protein’s replication rate bIg (b=d=bIg=0.1) and the system evolves to 
achieve high stabilities for normal proteins of cells and their weak interaction with Ig 
proteins to minimize the autoimmunity effects. Due to the differences between the time 
scales of protein evolution and a much faster response to a viral infection, the population 
dynamic simulation proceeds in two steps. For 1500 initial time steps, the system 
including cells and antibodies are allowed to evolve with mutation rate of functional 
proteins of the cell and Ig proteins, mcell=mIg=0.05 (attempted mutations per gene per unit 
time) in order to equilibrate the system. At t=1501, we select one cell whose averaged 
maximum Pint(Ig,gi) over all antibodies in the system has lowest value and replicate it 
5000 times in order for all cells to have the same genome at the moment of virus 
infection. All other cells are removed. Then, the attempted mutation rates of functional 
proteins of the cell and Ig proteins is reduced to mcell=0.0001 and mIg=0.005 respectively, 
and the system evolves for 500 time steps to re-equilibrate  at new mutation rates. At 
t=2001, 1000 identical free viruses are introduced in the system, starting the infection 
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with the viral infection rate, 0.75. The sequence of viral protein is designed for the initial 
stability Pnat(v)=0.66 and the averaged initial protein interaction strength between Ig 
proteins and viral protein is Pint(Ig,v)=0.15. The viral replication rate constant b0v and the 
lysis threshold are set to 0.79 and 4 respectively. After infection, the system evolves up to 
t=4000. In reality, B-cells divide 3~4-fold faster when activated than normal (Janeway et 
al. 2001) and we set B-cell activation factor to α=5.0 to obtain 3~4-fold faster activation 
at a moderate antibody-antigen interactions strengths Pint(Ig,v)=0.4~0.7. 
 
Sequence entropy calculation 
 
In order to analyze the degree of diversity of Ig proteins, we calculated the 
sequence entropy of Ig proteins. The sequence entropy of a residue in k-position is 
defined as following (Yano and Hasegawa 1974). 
 Sk = − Pik log
i=1
20∑ Pik  (S7) 
,where Pik is  frequency of  amino acid of type i in k-position in a multiple sequence 
alignment. The sequence entropy for the whole Ig protein is obtained by averaging over 
all 27 positions in its sequence. 
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Figure S1. 
The snapshot of two interacting lattice proteins. Two proteins in 3x3x3 lattice are 
presented in backbone diagram. Two proteins are interacting with each other as sharing 9 
interaction bonds, which is presented with black dotted lines. 
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Figure S2. 
The simulation procedure. The initial simulation runs up to t=1500 with the high 
mutation rates of cells and antibodies (mcell=mIg=0.05 attempted mutations per gene per 
unit time). And then, the attempted mutation rates of functional proteins of the cell and Ig 
proteins is reduced to mcell=0.0001 and mIg=0.005 respectively, and the system evolves 
for 500 time steps to re-equilibrate it. At t=2001, 1000 identical virus particles starts to 
infect cells in the system. 
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Figure S3. 
Observed mutation rate of Ig gene. The black dots represent the average accumulated 
number of mutations in Ig genes in the healing case (mv=0.0003 and mIg=0.08). A 
linear fit estimate (red dashed line) corresponds to the observed mutation rate of 
Ig gene   %mIg =0.04 (mutations per gene of 81 nucleotides per time step). In the 
presence of virus, the division rate of (activated) B-cells increases to ~0.4, so B-
cell division time is 2.5 time steps. Therefore, the observed mutation rate of Ig 
gene is at least 1.2x10-3 mutations per bp per division (neglecting the redundancy 
of the genetic code), which is comparable to the somatic hypermutation rates 
estimated by Kleinstein 
